2019 Pediatric Rx, Module 4- GI Drugs

Introduction:

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.75 NAPNAP contact hours, of which 0.75 is pharmacology.

IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

Copyright 2019 © by National Association of Pediatric Nurse Practitioners (NAPNAP)

Target Audience

Pediatric-focused advanced practice registered nurses

Learning Objectives

  • Will have up-to-date information on current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.
  • Evaluate critically the safety and efficacy of GI drugs in children.
Course summary
Available credit: 
  • 0.75 Contact hours
Course opens: 
12/02/2019
Course expires: 
11/30/2021
Cost:
$15.00

Teri Moser Woo, PhD, CPNP-PC, CNL, FAANP:  Professor and Director of Nursing, Saint Martin’s University; PNP, Pediatric Urgent Care for Woodcreek Pediatrics, Puyallup, Wash.
 

FACULTY DISCLOSURES 
 

Dr. Moser Woo has no relevant financial relationships to disclose.

Available Credit

  • 0.75 Contact hours

Accreditation Period

Course opens: 
12/02/2019
Course expires: 
11/30/2021

Price

Cost:
$15.00
Please login or register to take this course.